At the first visit, baseline measures will be assessed and information about the study will be given. During the first week of the study data about your sleep and general health will be collected. At visit 2 you will be randomly assigned to either the active medication or a no-treatment condition, followed by another week of data assessment and a last visit.
You will be reimbursed for the costs associated with participating.
Ethics approval number: 2018/107
You may be eligible to participate in this study if you must be :
If you are interested in participating, or need any additional information about the study please feel free to contact Christoph Werner by email here and you will be sent an information sheet.